AFT Pharmaceuticals confirms dual-listing plans to fund R&D, global growth

AFT Pharmaceuticals confirms dual-listing plans to fund R&D, global growth
Paul McBeth
By Paul McBeth Oct. 9 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based drugs developer and reseller, wants to list in Australia and New Zealand, raising funds to speed up the development of products to sell in other countries. The company is considering an initial public offering on the NZX and ASX, hiring First NZ Capital as sole lead manager, it said in a statement, without indicating how much money it wants to raise. The funds raised will go towards completing clinical product development and introducing those drugs into foreig...